Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Aim: It is not well known how comorbidities may change the prognosis of atrial fibrillation (AF) patients. This study was aimed to analyze the impact of cardiovascular disease on this population. Materials & methods: EMIR was a multicenter, prospective study, including 1433 AF patients taking...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Becaris Publishing Limited
2023-02-01
|
Series: | Journal of Comparative Effectiveness Research |
Subjects: |